Tyrosine kinase inhibitors potentiate the cytotoxicity of MDR-substrate anticancer agents independent of growth factor receptor status in lung cancer cell lines. (Q39842390)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q37829209)
(Q81251880)
(Q57002381)
(P304) 433-444
(P407) (Q1860)
(P433) 4
(P478) 28
(P577) Friday, June 5, 2009
(P921) (Q246181)
(P1433) (Q2312231)
(P1476) "Tyrosine kinase inhibitors potentiate the cytotoxicity of MDR-substrate anticancer agents independent of growth factor receptor status in lung cancer cell lines" (language: en)
(P2093) J Crown
N O'Donovan
A Devery
F O'Sullivan
M Clynes
(P2860) (Q41597554)
(Q34524629)
(Q30657347)
(Q58838535)
(Q36513881)
(Q36554418)
(Q45871082)
(Q37117151)
(Q41649455)
(Q40330401)
(Q40050525)
(Q40390330)
(Q36265658)
(Q37119716)
(Q33211184)
(Q43658492)
(Q53919691)
(Q34322472)
(Q40168706)
(Q40126091)
(Q40410062)
(Q34268081)
(Q41587482)
(Q28256478)
(Q40553425)
(Q28280609)
(Q34242076)
(Q73526045)
(Q36140967)
(Q34502459)
(Q27851403)
(Q36386127)
(Q24811895)
(Q44135091)
other details
description scientific article

External Links